+966 568813716 [email protected]

E-Lessons

Home / Archive by category "E-Lessons" (Page 7)
18
Aug
2018
IMPROVE YOUR ENGLISH IN A MINUTE= TAKE
Posted On August 18, 2018  By Dr.Adel Serag  And has No Comment

Read More

21
Jul
2018
Don’t Diet and loose weight
Posted On July 21, 2018  By Dr.Adel Serag  And has No Comment

If you’re struggling to lose weight, you probably feel like the odds are stacked against you. You’re not necessarily wrong. “There is so much great-tasting food, and it’s abundant and in your face all the time. To me it’s kind of a miracle that people aren’t […]

Read More

20
Jul
2018
Electro-Convulsive therapy : Facts and Myths
Posted On July 20, 2018  By Dr.Adel Serag  And has No Comment

As evidence supporting the use of electroconvulsive therapy (ECT) to treat patients with depression and other psychiatric illnesses continues to grow, myths about this treatment persist. In light of these myths, patients might be reluctant to receive ECT. As clinicians, we need to educate patients about […]

Read More

18
Jul
2018
Personality disorders one sheet
Posted On July 18, 2018  By Dr.Adel Serag  And has No Comment

  If personality is the cluster of traits which form the uniform of the one either he or She. Magnified certain traits in one person can be disturbing others but the person himself/herself might not feel disturbed. Here is the sum of personality disorders cluster traits. […]

Read More

14
Jul
2018
CLOZAPINE
Posted On July 14, 2018  By Dr.Adel Serag  And has No Comment

Clozapine What’s of Interest: Clozapine REMS and ANC monitoring update Brands Clozaril, Leponex, Versacloz (oral suspension), Fazaclo ODT (oral disintegrating tablet) Class Atypical antipsychotic (serotonin-dopamine antagonist; second-generation antipsychotic; also a mood stabilizer) Approved For: Treatment-resistant schizophrenia   Reduction in risk of recurrent suicidal behavior in patients […]

Read More

12
Jul
2018
Agomelatin = Valdoxan
Posted On July 12, 2018  By Dr.Adel Serag  And has No Comment

1 AGOMELATINE THERAPEUTICS Brands • Valdoxan see index for additional brand names Generic? No Class • Neuroscience-based Nomenclature: melatonin multi-modal (Mel-MM) • Agonist at melatonergic 1 and melatonergic 2 receptors • Antagonist at 5HT2C receptors Commonly Prescribed for (bold for FDA approved) • Depression How the […]

Read More

11
Jul
2018
Lurasidone : Latuda
Posted On July 11, 2018  By Dr.Adel Serag  And has No Comment

What’s of Interest: Latuda is now approved for pediatric bipolar depression (ages 10 and older) Brands Latuda Class Atypical antipsychotic (serotonin-dopamine antagonist; second generation antipsychotic; also a mood stabilizer) Approved For: Schizophrenia (ages 13 and older) Bipolar depression (ages 10 and older, monotherapy) Bipolar depression (adults, […]

Read More

04
Jul
2018
Psychiatry’s ‘C’ words
Posted On July 4, 2018  By Dr.Adel Serag  And has No Comment

      Current Psychiatry. 2018 July;17(7):4,6 By Henry A. Nasrallah, MD Recently, contemporary “culture” has capriciously confounded and confused our national community with a cringe-worthy “C” word. Unfortunately, this was followed by only transient public consternation, reflecting the coarsening of our social communication and discourse and the cant of many. But the ripple effects continue. As […]

Read More

04
Jul
2018
New marijuana-based pharmaceutical drug approved by FDA
Posted On July 4, 2018  By Dr.Adel Serag  And has No Comment

What is Epidiolex? Epidiolex is an oral liquid-based drug made from the cannabidiol (CBD) portion of cannabis. Compared to the tetrahydrocannabinol (THC) portion, CBD is not psychoactive, so taking this drug would not result in a high for the user. CBD acts on different parts of […]

Read More

02
Jun
2018
May 21, 2018   :FDA Approves First Non-Opioid to Treat Opioid Withdrawal Symptoms 
Posted On June 2, 2018  By Dr.Adel Serag  And has No Comment

    The US FDA has approved the first non-opioid treatment for the relief of opioid withdrawal symptoms. The medication, lofexidine hydrochloride (trade name Lucemyra), is an oral, selective alpha-2 adrenergic receptor agonist that reduces the release of norepinephrine, which may lead to relief of autonomic […]

Read More


Page 7 of 31